DocGo Inc Dossier
Financial Snapshot
Revenue, profitability, returns, debt, and capital allocation
Revenue $294.7M-52.2% YoYTTM through 30 Jun 2026
Net Income -$192.4M-1,062.5% YoYTTM through 30 Jun 2026
Free Cash Flow -$25.8MTTM through 30 Jun 2026
Margins
| Current | |
|---|---|
| Gross Margin | 25.8% |
| EBITDA Margin | -57.7% |
| Operating Margin | -55.3% |
| Net Margin | -65.3% |
Returns
-161.6%ROE
-103.0%ROA
Balance Sheet Health
Debt / Equity0.26x
Current Ratio1.79x
Net Debt-$7.2Mnet cash position
Cash & Equivalents$25.2M
Quality Metrics
Altman Z-Score-2.73
Piotroski F-Score2 / 9
FCF Margin-8.8%
Rule of 40-5.4
Earnings-Beat Rate50.0%
Multi-Year Trend
RevenueFY2025: $322.2M
Diluted EPS-$1.94TTMFY2025: $-1.84
Dividend
No dividend
Capital Allocation
R&D Spend$14.1M
Capex Intensity1.1%
Segment Performance
| Segment | Revenue | YoY | Outlook |
|---|---|---|---|
| Medical Transportation Services | $200.8M | +3.8% | |
| Mobile Health Services | $121.4M | -71.3% |
Filing Detail Members
This section is available to registered members. Create a free account or sign in to unlock the full breakdown.